Quoin Pharmaceuticals Ltd
Research Quoin Pharmaceuticals Ltd (QNRX) on Bullrun: market cap USD 8.76M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerQNRX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 8.76M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 5.37M
- Free cash flow-USD 3.14M
Valuation Snapshot
latest market cap is USD 8.76M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 15.80M | -USD 13.54M | n/a | -14.8 | USD 3.82M | n/a | USD 13.12M |
| FY2024 | USD 0 | -USD 8.96M | -USD 7.86M | n/a | -66.85 | USD 3.62M | n/a | USD 9.20M |
| FY2023 | USD 0 | -USD 8.69M | -USD 7.86M | n/a | -337.47 | USD 2.40M | n/a | USD 5.66M |
| FY2022 | USD 0 | -USD 9.38M | -USD 8.73M | n/a | -1638.23 | USD 2.86M | n/a | USD 7.41M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 8.76M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 21.62M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.82M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 4.84M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 6.86M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 15.29M | n/a | n/a | n/a |
About Quoin Pharmaceuticals Ltd
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Quoin Pharmaceuticals Ltd's market cap?
Quoin Pharmaceuticals Ltd's market capitalization is USD 8.76M.
What does Quoin Pharmaceuticals Ltd do?
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis.